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Inhibition of autophagy, lysosome and VCP function
impairs stress granule assembly
SJ Seguin1, FF Morelli1, J Vinet1, D Amore1, S De Biasi2, A Poletti3, DC Rubinsztein4 and S Carra*,1
Stress granules (SGs) are mRNA-protein aggregates induced during stress, which accumulate in many neurodegenerative
diseases. Previously, the autophagy-lysosome pathway and valosin-containing protein (VCP), key players of the protein quality
control (PQC), were shown to regulate SG degradation. This is consistent with the idea that PQC may survey and/or assist SG
dynamics. However, despite these observations, it is currently unknown whether the PQC actively participates in SG assembly.
Here, we describe that inhibition of autophagy, lysosomes and VCP causes defective SG formation after induction. Silencing the
VCP co-factors UFD1L and PLAA, which degrade defective ribosomal products (DRIPs) and 60S ribosomes, also impaired SG
assembly. Intriguingly, DRIPs and 60S, which are released from disassembling polysomes and are normally excluded from SGs,
were significantly retained within SGs in cells with impaired autophagy, lysosome or VCP function. Our results suggest that
deregulated autophagy, lysosomal or VCP activities, which occur in several neurodegenerative (VCP-associated) diseases, may
alter SG morphology and composition.
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Cells respond to stresses, like heat shock or oxidative agents,
which lead to protein aggregation, by activating the protein
quality control (PQC) and attenuating translation.1 The PQC
consists of molecular chaperones and degradation systems
and is an essential player of the proteotoxic stress response.
To minimize protein aggregation, chaperones assist
protein folding; when this is not effective, chaperones
assist in targeting damaged substrates for clearance by the
ubiquitin–proteasome system (UPS) and the lysosome-based
degradation systems.2,3 In parallel, polysomes disassemble,
releasing ribosomes, mRNAs, defective ribosomal products
(DRIPs) and newly synthesized proteins, which, due to the
stress, are prone to aggregation and are subjected to PQC
and degradation.4
The mRNAs encoding ‘housekeeping’ proteins released from
disassembling polysomes are sequestered into stress granules
(SGs), non-membranous cytoplasmic foci where mRNAs are
stored during stress.5 SGs have heterogeneous compositions
and contain translationally silent mRNAs, early initiation factors,
small, but not large, ribosomal subunits, mRNA-binding
proteins, kinases and signaling molecules.5 Selective seques-
tration of these components within SGs occurs in a challenging
subcellular environment where aggregate-prone substrates
(released by polysomes) tend to accumulate. SG assembly is
also triggered by the self-aggregation of RNA-binding proteins
that contain prion-like domains, including T-cell-restricted
intracellular antigen-1 (TIA-1).6 Unlike prionogenic fibrillar
aggregates, SGs are dynamic structures, which disassemble
within few hours after their formation.
Due to the heterogeneous composition of SGs and to the
crowded molecular environment, SGs may, indirectly, require
PQC assistance for proper assembly and disassembly.
A number of SG components have a role in PQC, including
ubiquitin and E3 ubiquitin ligases (TNF receptor-associated
factor 2 and Roquin),7–10 while proteasome inhibition induces
SGs.11 Histone deacetylase 6 (HDAC6), another SG compo-
nent,8 facilitates the clearance of misfolded ubiquitinated
proteins and participates in their targeting to the aggresome,
a perinuclear structure that forms in response to an overload
of un/misfolded proteins and enhances the degradation
of toxic proteins.12 Moreover, HDAC6 binds to another SG
component, Ras-GTPase-activating protein SH3 domain-
binding protein (G3BP), which modulates the de-ubiquitinat-
ing enzyme ubiquitin specific peptidase 10 (USP10), which is
also required for SG formation.13,14 Although the exact role
of these PQC components in SG dynamics is only partly
understood, these findings suggest that PQC and SGs are
interconnected systems. SGs are degraded via macroauto-
phagy (which we call autophagy) via a mechanism requiring
the ubiquitin-selective chaperone valosin-containing
protein (VCP).15 VCP modulates the ubiquitin-dependent
proteolysis of selective clients by proteasome, ER-associated
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Figure 1 Lysosomotropic agents severely impair SG formation. HeLa cells treated for 3 h with MG132 alone or with ammonium chloride (NH4Cl; a, b) or chloroquine
(CLQ; b) were fixed and labeled with anti-TIA-1, LC3 and DAPI. (b) Percentage of cells with TIA-1-positive SGs is shown (M¼MG132; N¼NH4Cl; C¼CLQ). Error bar,
S.E.M. ***Po0.001 compared with MG132. HeLa cells were treated for 45 min with 0.5 mM (c, d) or 0.1 mM (e, f) arsenite (Ars.); where indicated, cells were pretreated for 2 h
15 min with ammonium chloride (NH4Cl). Cells were fixed and labeled with anti-TIA-1, LC3 (c) or G3BP (e) and DAPI. (d, f) Percentage of cells with TIA-1-positive SGs (large
or dispersed) and no SGs is shown. Error bar, S.E.M. (e) *Po0.05; **Po0.01; (f) ***Po0.001; **Po0.01 compared with Ars. 0.1 mM. (g, h) Hela cells pretreated or not
with ammonium chloride (NH4Cl) for 2 h 15 min were subjected to heat shock (HS) at 43.5 1C for 45 min, fixed and labeled with anti-TIA-1, LC3 and DAPI. (h) Quantitation
of data in g. Error bar, S.E.M. **Po0.01. (a, c, e, g) 2.5 magnification of the selected area. See also Supplementary Figures S1, S2 and S3
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degradation and/or autophagosomes;16–18 this underscores
the link between SGs and proteostasis. Here, we investigated
whether impairment of PQC, autophagy and lysosomes
affects SG assembly. We demonstrate that inhibition of
VCP, autophagy or lysosomes affects SG formation, mor-
phology and composition.
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Results
Lysosomal inhibition impairs SG formation. To assess
whether impairment of the PQC system may affect SG
formation, we induced SGs using the proteasome inhibitor
MG13211 and simultaneously inhibited the lysosomes, the
common endpoint for a number of degradation path-
ways.19,20 In line with previous reports,11 MG132 induced
SGs in ca 70% of the cells, with a maximal peak after 3 h;
SGs, which are dynamic, disappeared after 8 h of MG132
treatment (Supplementary Figure S1A). Co-treatment of the
cells with MG132 and the lysosomal inhibitors ammonium
chloride (NH4Cl) or chloroquine (CLQ) suppressed MG132-
induced SGs (Figures 1a and b). We saw no SGs even after
8 h co-treatment with MG132 and NH4Cl (Supplementary
Figure S1A), which supports an inhibitory role, rather than a
delay, on SG formation. MG132 caused the accumulation of
ubiquitinated proteins, while NH4Cl increased levels of LC3-
II, the autophagosome-associated, lipidated form of LC3 that
accumulates if their lysosomal degradation is inhibited21
(Supplementary Figure S1A). When we monitored SGs and
the efficacy of NH4Cl, which causes a buildup of LC3-positive
autophagosomes, by immunofluorescence using antibodies
for TIA-1 and LC3, respectively, we observed LC3 recruit-
ment to SGs (Figure 1a).
Since drugs that stabilize polysomes (cycloheximide) inhibit
SG formation,22 we analyzed polysome distribution to test
whether NH4Cl prevented polysome disassembly. NH4Cl did
not alter the distribution of ribosomal protein S6 (RPS6), while
addition of EDTA to pelleted polysomes dissociated them, as
expected (Supplementary Figures S1B and C). MG132 alone,
or with NH4Cl, caused polysome disassembly, as no or only a
minor RPS6 signal was detected throughout the gradient
(Supplementary Figure S1C). Thus, NH4Cl prevents
MG132-induced SGs by acting downstream of polysome
disassembly.
Next, we tested if NH4Cl inhibited SG formation in response
to arsenite, which also leads to protein aggregation.23
Arsenite (0.5 mM) induced large SGs aligned in a ring-like
shape in nearly all the cells (number of SGs/cell: 10.5±0.3;
SG size: 2.03mM±0.05; Figures 1c and d). Pre-treatment
with NH4Cl modified the number, size and distribution of SGs,
which were more numerous, smaller (number of SGs/cell:
24.6±0.7; SG size: 0.94 mM±0.02) and dispersed through-
out the cytoplasm (Figures 1c and d). NH4Cl abrogated SG
formation when we used lower concentrations of arsenite
(0.1 mM), which did not lead to a maximal SG response
(Figures 1e and f).
SGs form as a consequence of translation arrest (but are not
required for translation arrest).24 Translational status was
assessed using puromycin, which is incorporated into nascent
peptides.25 Puromycin-labeled proteins were detected in
control cells and cells treated with NH4Cl, but not after treatment
with arsenite alone or combined with NH4Cl (Supplementary
Figure S1D). In parallel, polysomes disassembled after arsenite
and NH4Cl co-treatment (data not shown).
Assembly of SGs is triggered by the self-reversible
aggregation of components that contain a prion-like domain,
including TIA-1.6 We excluded that the small and dispersed
structures that form in cells co-treated with arsenite and
NH4Cl are proteinaceous aggregates rather than bona fide
SGs, since both G3BP, a well-known SG marker (Figure 1e),
and RNA, labeled using SYTO RNASelect (Supplementary
Figure S2A), colocalized with TIA-1 in these cells.
To generalize the inhibitory effect of NH4Cl on SGs, we
induced SGs with heat shock; NH4Cl also decreased the
formation of heat shock granules (Figures 1g and h). Then, to
further test the importance of lysosomes in SG formation, we
used different combinations of lysosomal protease inhibitors
leupeptin, E64d and pepstatin A. While NH4Cl and CLQ inhibit
the activity of all lysosomal acid hydrolases, these inhibitors
selectively target the activity of specific classes of proteases.
Pre-treatment with leupeptin and E64d or leupeptin, E64d
and pepstatin A caused both LC3-II accumulation and
reduced MG132-induced SGs (Supplementary Figure S2B).
LC3 recruitment into SGs was found under all stress
conditions tested and was confirmed using three LC3
antibodies (Supplementary Figure S2C; Figures 1a, c
and g). To determine which form of LC3, cytosolic LC3-I or
autophagosome-anchored LC3-II, is recruited into SGs, we
used Atg5 (autophagy gene 5) knockout ( / ) MEFs; these
cells lack the autophagy ATG5 gene required for LC3-I to
LC3-II conversion (Figure 2d).26 Also in Atg5 / MEFs, SGs
were positive for LC3, suggesting that it is cytosolic LC3-I that
is recruited into SGs and consistent with SGs being
non-membranous foci (Supplementary Figure S2D). NH4Cl
impaired SG formation in Atg5 / and Atg5þ /þ MEFs,
generalizing its inhibitory effect to different cell lines (Figures
2a–f). After MG132 or arsenite treatments, the percentage of
cells positive for SGs was significantly reduced in Atg5 /
MEFs, as compared with Atg5þ /þ MEFs (Figures 2a–f),
thereby suggesting a potential interplay between autophagy
and SGs. We further tested this hypothesis by using MEFs
lacking the ATG16 gene, which is essential for autophago-
some formation,27 as evidenced by the lack of LC3-II in
Atg16 / cells (Figures 2g and h). Similar to Atg5 / cells,
Figure 2 Atg5 and Atg16 null cells show impaired SG formation. (a–d) Atg5þ /þ or Atg5 / MEFs were left untreated or treated for 3 h with MG132 and/or ammonium
chloride (NH4Cl) and either fixed and labeled with anti-TIA-1, LC3 and DAPI (a–c) or processed for western blot (d). (c) Quantitation of data in a and b. Error bar, S.E.M.
**Po0.01 compared with MG132 in Atg5þ /þ . (e, f) Atg5þ /þ and Atg5 / MEFs were treated for 45 min with arsenite (Ars.); where indicated, MEFs were pretreated for 2 h
15 min with 20 mM ammonium chloride (NH4Cl). Cells were fixed and labeled with anti-TIA-1, LC3 and DAPI. Quantitation of data is shown. Error bar, S.E.M. ***Po0.001;
*Po0.05 compared with Ars.; ##Po0.01 Ars-treated Atg5 / compared with Atg5þ /þ . (g) Atg16þ /þ and Atg16 / MEFs were treated for 3 h with MG132 or for 45 min
with Ars., fixed and labeled with anti-TIA-1, LC3 and DAPI. Quantitation of data is shown. Error bar, S.E.M. ***Po0.001; **Po0.01. (h) Atg16þ /þ and Atg16 / MEFs
were treated as described in a; where indicated cells were pretreated for 2 h 15 min with ammonium chloride (NH4Cl), prior to lysis and western blot. (i) m5-7 cells were grown
for 7 days without ( ) or with (þ ) tetracycline (500 ng/ml), prior to addition of ammonium chloride (NH4Cl) or MG132 for 3 h. Cells were processed for western blot
or fixed and labeled with anti-TIA-1 and DAPI. Quantitation of data is shown. Error bar, S.E.M. ***Po0.001 compared with MG132 condition. (h, i) * likely corresponds to LC3
T. (a, b, e–g) 2.5 magnification of the selected area
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Atg16 / cells showed impaired SG formation following
MG132 or arsenite treatments (Figure 2g). However, NH4Cl
has an additional inhibitory effect on SGs in Atg5 / cells
(Figure 2f), suggesting that other macroautophagy-indepen-
dent routes may contribute to SG formation.28 Finally, to
confirm whether autophagy influences SG assembly, we used
Protein quality control and stress granules
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modified Atg5 / MEFs that express an ATG5 transgene
which is negatively regulated by tetracycline (m5-7), allowing
inducible suppression of autophagy in the same cell line.29
Addition of tetracycline to the m5-7 cells suppressed LC3
lipidation (Figure 2i). MG132 treatment induced SGs in ca
25–30% of autophagy-competent m5-7 cells grown in the
absence of tetracycline, similar to what was observed
in Atg5þ /þ MEFs (Figure 2, compare c and i). Addition
of tetracycline to these m5-7 cells, which switches off
autophagy/ATG5 expression, impaired MG132-induced SGs
(Figure 2, compare c and i). Thus, inhibition of autophagy and
lysosomes impairs SG assembly. This is complementary to
recent findings demonstrating that SGs are cleared by
autolysosomes and accumulate during the recovery, if
autophagy is inhibited15 (a phenomenon we confirmed;
Supplementary Figure S3A).
While NH4Cl (and CLQ) abrogated SG formation induced
by MG132, they severely impaired (but did not block) SG
formation by arsenite (0.5 mM) or heat shock. We thus
hypothesized that interplay between proteasome and lyso-
somes may exist and modulate SG assembly. To address this
hypothesis, we treated HeLa cells with MG132 and arsenite
(0.5 mM), which together induce large SGs in all cells
(Supplementary Figures S3B and C). Addition of NH4Cl
inhibited SG assembly (Supplementary Figures S3B and C).
Next, we used a low dose of Bortezomib, which inhibits the
proteasome but does not induce SGs (Supplementary
Figures S3D and E). Overnight pre-treatment with Bortezomib
inhibited arsenite-induced SGs (Supplementary Figures S3D
and E). These results support that interplay between protea-
some and lysosomes is required for optimal SG assembly.
We thus asked how inhibition of the main protein degrada-
tion pathways may impair SG formation. While the 70 kd heat
shock protein (Hsp70) overexpression inhibits SG forma-
tion,11 we did not observe major induction of Hsp70 after
short-term co-treatments with MG132 or arsenite and NH4Cl
(Supplementary Figure S3F), or with overnight treatment with
leupeptin, E64d and pepstatin A (Supplementary Figure
S3G). Upregulation of Hsp70 was only found after overnight
treatment with bortezomib (Supplementary Figure S3G).
Thus, SG formation is not impaired by Hsp70 upregulation
in our experimental conditions. Phosphorylation of the alpha
subunit of translation initiation factor 2 (eIF2a) is required for
the induction of SGs upon arsenite, but not MG132.30 Arsenite
alone or in combination with NH4Cl induced eIF2a phosphor-
ylation (Supplementary Figure S3H), pointing to a different
mechanism responsible for impaired SG assembly upon
lysosome inhibition. We excluded the possibility that
apoptosis may account for our observations, since pre-
treatment with the pan-caspase inhibitor zVAD-fmk could
not rescue the inhibitory effect exerted by NH4Cl on MG132-
or arsenite-induced SGs (Supplementary Figure S3I), and the
percentage of apoptotic and necrotic cells and cells with
depolarized mitochondria were similar under all conditions
tested both in HeLa (Supplementary Table S1) and autop-
hagy-proficient/deficient cells (Supplementary Table S2).
Depletion of VCP impairs SG formation. VCP knockdown
in HeLa cells led to accumulation of ubiquitinated proteins
and LC3-II (Figure 3a)17 and decreased SG formation
induced by MG132 and arsenite (Figures 3b and c). The
arsenite-induced SGs forming in VCP-deficient cells also
contained LC3 (Figure 3b), supporting that LC3 recruitment
within SGs is independent on VCP. Two well-known
inhibitors of VCP, Eeyarestatin I (EerI) and ML240 led to a
mild accumulation of ubiquitinated proteins, while only
ML240 also caused LC3-II buildup, in line with previous
findings (Figure 3d);31 however, they did not induce poly ADP
ribose polymerase (PARP) cleavage or Hsp70 (Figure 3d).
Neither EerI nor ML240 induced SGs (data not shown);
instead, they impaired SG assembly following MG132 or
arsenite treatment (Figure 3e), consistent with what we
observed with VCP knockdown.
Prior to SG formation, polysomes disassemble and release
ubiquitinated un/misfolded proteins, DRIPs and ribosomal
subunits (Figure 3f). DRIPs, which represent ca the 30% of
newly synthesized proteins,4 are aggregation-prone and may
possibly affect the reversible self-aggregation of TIA-1, which
drives SG formation.6 In addition, while the small ribosomal
subunit (40S) is a component of SGs, the large one (60S) is
excluded from and antagonistic to SGs.22,32 To enable client
selection, VCP interacts with co-factors, like ubiquitin fusion
degradation 1 like (UFD1L) and phospholipase A2-activating
protein (PLAA). UFD1L promotes with VCP the degradation of
DRIPs bound to translating ribosomes33 (Figure 3f). PLAA
forms a complex that also contains HDAC6, a SG compo-
nent.34 This complex modulates ubiquitin turnover and client
transfer to HDAC6 for targeting to aggresome.34–36 VCP and
PLAA are also required in yeast for ribophagy, the lysosome-
mediated degradation of 60S37,38 (Figure 3f). We speculated
that defective clearance of DRIPs and 60S mediated by
lysosome/autophagy, proteasome and VCP (and co-factors),
may contribute to impaired SG growth. In line with this
hypothesis, knockdown of PLAA (Figures 4a–c) or UFD1L
(Figures 4d–f) impaired MG132 and arsenite-induced SGs,
although their effect was less severe than VCP knockdown.
Figure 3 Depletion and inhibition of VCP severely impair SG formation. (a–c) HeLa cells lipofected with control (ctrl) or VCP siRNA for 72 h were left untreated (data not
shown) or treated for 3 h with MG132 or 45 min with arsenite (Ars.) Cells were lysed, processed for western blot (a) or fixed and labeled with anti-TIA-1, LC3 and DAPI (b).
(c) Quantitation of data in b. Error bar, S.E.M. **Po0.01; ***Po0.001. (d) HeLa cells not treated or treated for 3 h with ML240 or EerI were lysed and processed for ubiquitin,
PARP (c.f.: cleaved-fragment), Hsp70, LC3 and a-tubulin western blot. (e) Cells were treated for 3 h with MG132 or for 45 min with Ars. alone or in combination with ML240 or
EerI; cells were fixed and labeled with anti-TIA-1, G3BP and DAPI. Quantitation of data is shown. Error bar, S.E.M. For MG132 co-treatments: ***Po0.001 compared with
MG132 alone; for Ars. co-treatments: ***Po0.001; **Po0.01; *Po0.05 compared with Ars. alone. (f) Schematic model of the known role of VCP in targeting DRIPs and
large ribosome subunits (60S) to degradation. Polysomes are a cluster of ribosomes that synthesize nascent chains from mRNAs. Upon stress, including MG132 or arsenite
treatments, polysomes disassemble and their components follow different fates. mRNAs together with initiation factors and the small (40S) ribosome subunit are sequestered
into stress granules (SGs). DRIPs are ubiquitinated and routed to degradation. VCP bound to 60S modulates the degradation of DRIPs. Co-factors such as UFD1L and PLAA
assist VCP in client targeting to both proteasome and autophagy for clearance. In parallel, 60S are also released but are excluded from SGs and can become damaged under
stress conditions (e.g., oxidation due to arsenite). 60S are targeted to lysosome for degradation, a process called ribophagy. VCP and PLAA are also required in yeast for
ribophagy. (b, e, f) 2.5 magnification of the selected area. See also Supplementary Figure S4
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Figure 4 Depletion of the VCP co-factors PLAA and UFD1L affects SG formation. HeLa cells lipofected with control (ctrl), PLAA (a–c) or UFD1L siRNA (d–f) for 72 h were
left untreated (data not shown) or treated for 3 h with MG132 or 45 min with arsenite (Ars). Cells were lysed and processed for western blot (a, d), or fixed and labeled with anti-
TIA-1, LC3 and DAPI (c, f). (b, e) Quantitation of data in c and f. Error bar, S.E.M. ***Po0.001; **Po0.01; *Po0.05. (c, f) 2.5 magnification of the selected area. See also
Supplementary Figure S4
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Figure 5 Inhibition of proteasome and lysosome or silencing of VCP and co-factors lead to the accumulation of OP-puro-labeled DRIPs adjacent to or within SGs. (a–c)
HeLa cells were co-treated for 45 min with OP-puro and arsenite (Ars.); where indicated, cells were pretreated with bortezomib (Bort.) overnight and/or ammonium chloride
(NH4Cl) for 2 h 15 min. Cells were fixed and labeled with Alexa594–Azide and anti-TIA-1. (b) The number of OP-puro puncta per cell is shown. Error bar, S.E.M. ***Po0.001
compared with Ars. (c) The percentage of OP-puro puncta adjacent to/colocalizing with SGs is shown. Error bar, S.E.M. ***Po0.001 compared with Ars. (d) HeLa cells
lipofected for 72 h with control, VCP, PLAA or UFD1L siRNA were treated for 45 min with OP-puro and Ars., fixed and stained with Alexa594–Azide, anti-TIA-1 and DAPI.
Arrowheads indicate OP-puro-labeled DRIPs colocalizing with TIA-1-positive SGs. The percentage of OP-puro puncta adjacent to/colocalizing with SGs is shown. Error bar,
S.E.M. ***Po0.001 compared with cells transfected with control siRNA. (a, d) 2.5 magnification of the selected area. See also Supplementary Figure S5
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Silencing VCP, PLAA and UFD1L also inhibited heat
shock-induced SGs (Supplementary Figure S4A). Knock-
down of VCP, PLAA or UFD1L did not induce Hsp70
(Supplementary Figure S4B) or apoptosis/PARP cleavage
(Supplementary Figures S4B–D; PARP was slightly cleaved
in VCP-depleted cells). As positive control, PARP cleavage
Figure 6 Chemical inhibition of lysosomes or genetic perturbation of autophagy leads to formation of SGs that contain RPL19. (a, b) HeLa cells were treated for 45 min with
arsenite (Ars.) alone or following ammonium chloride (NH4Cl) pre-treatment. Cells were fixed and labeled with anti-TIA-1, RPL19 and DAPI. (b) Quantitation of colocalization of
RPL19 and TIA-1 is shown. Error bar, S.E.M. **Po0.01. (c, d) Cells treated as described in a were fixed, subjected to in situ hybridization with a 28S rRNA probe coupled to
Alexa594 and labeled with anti-G3BP and DAPI. (d) Quantitation of the % of TIA-1-positive SGs located outside or inside the 28S rRNA perinuclear-enriched region is shown. Error
bar, S.E.M. *Po0.05. (e, f) Atg16þ /þ , Atg5 / and Atg16 / MEFs were treated for 45 min with Ars. and labeled with anti-TIA-1, RPL19 and DAPI. (f) Quantitation of
colocalization of RPL19 and TIA-1 is shown. Error bar, S.E.M. **Po0.01. (a–c) 2.5 magnification of the selected area. See also Supplementary Figure S6
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was induced with doxorubicin and was blocked by co-
treatment with zVAD-fmk (Supplementary Figure S4C). Like-
wise, co-treatment with zVAD-fmk could not rescue the
inhibitory effect of VCP or PLAA knockdown on SG assembly
(data not shown). Finally, SG response was not affected
in cells where ubiquitin-like-domain-containing protein
Ubxd8 (Ubxd8), another VCP co-factor, was silenced
(Supplementary Figures S4E–G). The VCP–Ubxd8 complex
promotes the release of ubiquitinated HuR from ribonucleo-
protein complexes;39 HuR is a component of SGs but it is not
required for their assembly.40 Thus, only a subset of VCP
complexes affects SGs.
DRIPs are excluded but adjacent to SGs. To test
whether accumulation of DRIPs occurs and correlates
with decreased SG formation, we labeled nascent chains
using O-propargyl-puromycin (OP-puro).25 Forty-five minutes
after treatment, aggregated OP-puro-labeled DRIPs
(stained with Alexa594–Azide) accumulated in the cytosol
(Supplementary Figures S5A and B). Only a background
Alexa594–Azide signal was detectable after co-treatment
with OP-puro and cycloheximide, a translation inhibitor,
demonstrating the specificity of OP-puro (Supplementary
Figure S5C). While at the concentration and time used,
OP-puro did not by itself induce SGs (Supplementary Figure
S5B), concomitant treatment with arsenite and OP-puro
induced SGs (Supplementary Figure S5D). DRIPs were
excluded from SGs, but could be found adjacent to SGs
(Supplementary Figure S5D, arrowheads). These OP-puro-
labeled products colocalized with ubiquitin (Supplementary
Figure S5E) and the autophagy adaptor sequestosome 1
(SQSTM1; Supplementary Figure S5F), which can target
certain ubiquitinated proteins, including DRIPs, to autopha-
gosomes/lysosomes.41 Indeed, partial colocalization of
DRIPs with LAMP2 (lysosomal associated membrane
protein-2) was found after co-treatment with OP-puro and
arsenite, supporting the fact that DRIPs released by
polysomes can be targeted to lysosomes (Supplementary
Figure S5G, arrowheads). Interestingly, while ubiquitin is a
component of SGs8 and colocalizes with DRIPs adjacent to
SGs (Supplementary Figures S5E and H), SQSTM1 only
colocalized with nascent chains and was excluded from SGs
(Supplementary Figures S5F and I). SQSTM1 adjacency to
SGs further points to a possible link between extraction of
ubiquitinated proteins, degradation systems and SG assem-
bly. Inhibition of proteasome and/or lysosome significantly
increased the number of OP-puro-labeled cytoplasmic
puncta suggesting that DRIPs are targeted to proteasome
and lysosome for disposal (Figures 5a and b). Bortezomib
and NH4Cl also increased the adjacency of DRIPs to SGs
(Figures 5a and c). Thus, if not properly degraded, nascent
peptides accumulate in the close vicinity of assembling SGs.
VCP, PLAA or UDF1L, which promote release and
degradation of nascent proteins from the ribosome33 and
which regulate SG assembly, colocalize with OP-puro-labeled
peptides (Supplementary Figures S5J–L). While arsenite-
induced SGs did not contain DRIPs in control cells (Figure 5d),
OP-puro-labeled peptides significantly colocalized with TIA-1
in SGs in VCP-, PLAA- or UFD1L-deficient cells (Figure 5d).
Thus, inhibition of lysosomes, VCP, PLAA and UFD1L leads
to formation of altered SGs that are adjacent to/contain
undigested DRIPs.
RPL19 is retained in SGs that form in cells with impaired
autophagy, lysosome or VCP. Upon proteotoxic stress,
polysomes disassemble and also release, besides DRIPs,
40S and 60S ribosomes. While 40S are recruited into SGs
(Supplementary Figure S6A), 60S are excluded from SGs
and antagonize SG formation22,32 (Figure 6a). Nonfunctional
60S degradation is regulated by diverse processes, including
VCP–UFD1 dissociation,42 which occurs following protea-
some inhibition and treatment with arsenite;42,43 ribophagy,37
which requires four players that also modulate SG assembly:
VCP (Cdc48), PLAA (Ufd3), USP10 (Ubp3) and G3BP
(Bre5)13,14,37,38 (and our results; Figures 3 and 4); and
lysosomes, which directly digest rRNA.44 Thus, we asked
whether 60S accumulate adjacent to/within assembling SGs
after autophagy, lysosome or VCP inhibition, analogous to
what we observed with DRIPs. We assessed ribosomal
protein L19 (RPL19) and 28S rRNA, both 60S components.
RPL19 was devoid from both large and smaller SGs that
accumulated in HeLa cells treated with arsenite, while it
significantly colocalized with TIA-1 in SGs following co-
treatment with arsenite and NH4Cl (Figures 6a and b). In line
with this, 28S rRNA was excluded from the large SGs
induced by arsenite (Figure 6c), but showed a perinuclear-
enriched distribution with the SGs generally aligned outside
this region. Following exposure to arsenite and NH4Cl, we
observed a more disorganized distribution of SGs that were
smaller in size and accumulated in the 28S rRNA peri-
nuclear-enriched region (Figures 6c and d). Similar to HeLa
cells, arsenite-treated autophagy-proficient cells formed SGs
that did not contain RPL19 (Figures 6e and f). Instead,
RPL19 and TIA-1 colocalized in arsenite-induced SGs in
Atg5 / and Atg16 / cells (Figures 6e and f). In
autophagy-proficient cells co-treated with arsenite and
NH4Cl, TIA-1 colocalization with RPL19 was similar to that
seen in autophagy-deficient cells (Supplementary Figure
S6C). Finally, VCP-depleted cells showed increased coloca-
lization of RPL19 with TIA-1-positive SGs (Figures 7a and b)
and displayed higher basal levels of RPL19 (Figure 7c). The
spatial distribution of SGs and 28S rRNA was also affected in
VCP-deficient cells, where SGs accumulated in the 28S
rRNA-enriched perinuclear region (Figures 7d and e).
Together, our results demonstrate that cells with inhibited
autophagy, lysosome or VCP form SGs with altered
morphology that retain 60S components within or in their
close vicinity.
Discussion
The finding that SGs are targeted to autophagy for degrada-
tion by VCP15 and that SG disassembly requires chaperone-
driven protein disaggregation45 are consistent with the idea
that PQC may survey and/or assist SG dynamics, both
assembly and disassembly. However, despite these observa-
tions, it was unclear whether the PQC actively participates in
SG assembly and whether impairments thereof affect SGs.
Our data demonstrate that inhibition of autophagy, lyso-
somes and VCP impairs SGs, supporting that the PQC
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modulates SG formation. Autophagy, lysosomes and VCP
govern protein (and organelle) degradation. In cells with
impaired autophagy, lysosome or VCP function, SGs were
smaller in size as compared with SGs forming in control cells.
This suggests that specific components may need to be
extracted from the foci where SGs assemble to be targeted to
degradation; this may indirectly contribute to optimal SG
growth. DRIPs and 60S are released by disassembling
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polysomes, prior to SG assembly, and are among the clients
that are cleared with the assistance of autophagy, lysosomes
and VCP.3,4,18,22,33,46–48 We found that DRIPs are excluded
from arsenite-induced SGs; however, upon UPS and lyso-
some inhibition, DRIPs accumulated adjacent to SGs. DRIPs
also significantly colocalized with SGs in VCP-, UFD1- and
PLAA-depleted cells, consistent with their role in handling and
degradation of DRIPs. These results suggest that impaired
extraction of DRIPs from the foci where SGs assemble may
affect SG composition and morphology (Figure 7f).
Ribosomes are also released by disassembling polysomes.
Only the 40S is a component of SGs, while the 60S is
excluded and impedes SG assembly.22 28S rRNA is enriched
in the perinuclear region and SGs form in the close vicinity of,
but always outside, this region. Instead, upon autophagy,
VCP or lysosomal inhibition, SGs tend to accumulate within
the perinuclear 28S rRNA-enriched region. Moreover, RPL19
colocalized with SGs in cells with impaired autophagy,
lysosome or VCP. Consistent with their role in ribophagy
and SG assembly13,14,38 (and Figures 3 and 4), inhibition of
VCP, autophagy or lysosome alters SG composition, mor-
phology and 60S distribution. This suggests that VCP may
participate in extracting 60S from the foci where SGs are
assembling. 60S can be next recycled or, when damaged due
to the proteotoxic stress that elicits SGs, targeted to
degradation via ribophagy, or both (Figure 7f). To what extent
60S are degraded or recycled, allowing polysome re-
assembly, is currently unknown. Our findings that RPL19
was trapped within SGs in cells with inhibited autophagy/
lysosome and VCP suggest that autolysosome-based degra-
dation of some 60S occurs concomitantly to SG assembly. At
this stage we cannot exclude that, besides DRIPs and 60S,
other components accumulate within SGs with altered
morphology that form in cells with proteostasis (autophagy,
lysosome and VCP) dysfunction, and that such additional
components may be major causes of the impaired SG
assembly. An important challenge for future work will be to
identify how VCP and co-factors orchestrate the selection of
components to be extracted from SGs and understanding LC3
role in SGs.
The discovery that autophagy, lysosome and VCP
inhibition affects SG morphology and composition implies
that proteostasis imbalances will have a direct impact
on SGs. This may render the cells vulnerable under
challenging/disease conditions. Indeed, recent data implicate
SGs and deregulated proteostasis in amyotrophic lateral
sclerosis, frontotemporal lobar degeneration and multi-
system proteinopathy, which are also associated with VCP
mutations49–54 and where protein aggregates that contain SG
components accumulate. Thus, inappropriate SG dynamics
may be relevant to pathogenesis. Our data are in line with this
hypothesis and demonstrate that SGs forming under condi-
tions of autophagy/lysosome or VCP inhibition accumulate
non-canonical components (DRIPs and 60S); this in
turn, can impair SG dynamics and contribute to SG
persistency. Persistent or partly disassembled SGs, if not
properly disposed,15 may act as seeds for aggregation,
further challenging protein and RNA homeostasis. In parallel,
SGs sequester pro-apoptotic factors, indirectly inhibiting
apoptosis.10,13,55 Although we could not detect any major
sign of toxicity under our experimental conditions (in line with
the findings from Buchan et al.15), we cannot exclude that, as
a consequence of proteostasis imbalances, chronic-impaired
SG formation may lead to, for example, deregulation
of signaling pathways and decreased sequestration of
pro-apoptotic factors, which could also contribute to cell
vulnerability/death.
Materials and Methods
Cell culture, treatments and transfection. HeLa cells, Atg16þ /þ ,
Atg16 / , Atg5þ /þ , Atg5 /and m5-7 MEFs were cultured in DMEM
(ECB7501L; EuroClone, Milan, Italy) supplemented with 2 mM L-glutamine,
100 U/ml penicillin/streptomycin and 10% fetal bovine serum (Lonza, Basel,
Switzerland) in a 37 1C incubator with 5% CO2.
Atg5þ /þ and Atg5 / MEFs were kindly provided by Dr. T Yoshimori
(Osaka University). Transfections were performed using Lipofectamine 2000
(Life Technologies, Monza, Italy) according to the manufacturer’s instructions.
All siRNAs used were from Dharmacon/GE Healthcare (Milan, Italy): siGENOME
non-targeting control siRNA, ON-TARGETplus VCP siRNA, ON-TARGETplus
PLAA siRNA, ON-TARGETplus UFD1L siRNA and ON-TARGETplus Ubxd8 siRNA.
Cells were treated with the following drugs at the concentrations indicated here:
arsenite 0.5 mM or, when specified, 0.1 mM; Z-Leu-Leu-Leu-al (MG132) 20 mM;
ammonium chloride (NH4Cl) 20 mM; CLQ 50mM; ML240 5 mM; EerI 10mM;
Bortezomib (Bort.) 100 nM; OP-puro 25 mM.
Immunofluorescence microscopy. Unless otherwise indicated, cells
were grown on coverslip, treated as indicated, washed with cold PBS and fixed
with 3.7% formaldehyde in PBS for 9 min at room temperature, followed by
permeabilization with cold acetone for 5 min at  20 1C. Blocking and incubation
with primary and secondary antibodies were performed in PBS containing 3% BSA
and 0.1% Triton X-100. Primary and secondary antibodies used are listed below.
Analysis of the cells was done by confocal imaging using a Leica SP2 AOBS
system (Leica Microsystems, Milan, Italy) and a 63 oil-immersion lens.
OP-puro labeling of cultured cells. The protocol for OP-puro labeling
was adapted from Liu et al.25 Cells were incubated with 25mM OP-puro for 45 min
and CuAAC detection of OP-puro incorporated into nascent proteins was
performed as previously described, using Alexa Fluor 594 azide (A10270, Life
Figure 7 RPL19 and 28S rRNA partly colocalize with arsenite-induced SGs in VCP-depleted cells. HeLa cells lipofected for 72 h with control or VCP siRNA were treated
for 45 min with arsenite (Ars.), fixed and labeled with anti-TIA-1, RPL19 and DAPI (a, b) or subjected to western blot (c) or to in situ hybridization with a 28S rRNA probe,
followed by co-staining with anti-G3BP and DAPI (d, e). (b) Quantitation of colocalization of RPL19 and TIA-1 is shown. Error bar, S.E.M. **Po0.01. (c) Quantitation of RPL19
protein levels is shown. Error bar, S.E.M. *Po0.05. (e) Quantitation of the % of TIA-1-positive SGs located outside or inside the 28S rRNA perinuclear-enriched region is
shown. Error bar, S.E.M. *Po0.05. (f) Schematic model of the proposed interplay between VCP, autophagy and SGs. Upon stress polysomes disassemble releasing DRIPs
and ribosome subunits (40S and 60S), while mRNA-binding proteins containing prion-like domains (e.g., TIA-1) trigger the sequestration of bound mRNAs into SGs. SGs also
contain, besides initiation factors, 40S and the autophagy protein LC3. Instead, DRIPs and 60S are excluded from assembled SGs. DRIPs and ubiquitinated unfolded proteins
are targeted to degradation by proteasome and autolysosomes with the assistance of VCP and its co-factors UFD1L and PLAA. Also damaged 60S can be targeted to
degradation by proteasome and/or lysosome, a process that also involves VCP and co-factors, while undamaged 60S can be recycled (not shown). Inhibition of autophagy or
lysosomes, as well as depletion of VCP (and the co-factors PLAA or UFD1L) leads to the accumulation of DRIPs and 60S within the foci where SGs are assembling. Under
such conditions, the SG response is decreased (in term of SG size and number) and SGs contain the non-canonical components DRIPs and 60S. (a, d) 2.5 magnification of
the selected area
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Technologies) (Liu J et al.25). Cells were next processed for immunofluorescence
microscopy as described above.
In situ hybridization. The in situ hybridization protocol was adapted from
Reineke et al.56 Cells were fixed with 2% formaldehyde in PBS for 1 min at room
temperature and permeabilized with ice-cold methanol for 10 min at  20 1C.
The following 50-biotinylated DNA probe was used to detect 28S rRNA:
50-cggcgctgccgtatcgttccgcctgggc gggattctgacttagaggcgttc-30. The probe was
hybridized in hybridization buffer (50% formamide, 2 SSC, 10% dextran
sulfate, 0.2% BSA, 5 mM DTT) at a final concentration of 1mg/ml for 24 h at 43 1C
in a humidified chamber and detected by subsequent incubation with Cy3
streptavidin (GE Healthcare Amersham, Milan, Italy) in 4 SSC plus 0.1% Triton
X-100 for 1 h at room temperature. Blocking and incubation with primary and
secondary antibodies were next performed as described above.
Western blotting. Cells were lysed in Laemmli buffer and protein samples
were boiled 3 min at 100 1C, separated by SDS-PAGE, transferred onto
nitrocellulose membranes, subjected to western blot analysis, and visualized
using an ECL detection kit (Thermo Scientific, Milan, Italy).
Antibodies and reagents. The primary antibodies used are listed. Mouse
anti-LAMP2 (H4B4), mouse anti-PARP-1(F-2), mouse anti-PLAA (E-1), mouse
anti-Ribosomal Protein L19 (K-12), mouse anti-SQSTM1 (D-3), mouse anti-UFD1
(19), rabbit anti-SQSTM1 (H-290), rabbit anti-ETEA (H-300) and goat anti-TIA-
1(C-20) were from Santa Cruz Biotechnology Inc. (Heidelberg, Germany). Mouse
anti-G3BP and mouse anti-HSP70 (SMC-100A/B) were from BD Biosciences
(Milan, Italy) and StressMarq Biosciences Inc., (Victoria, BC, Canada)
respectively. Mouse anti-Ribosomal Protein L19 and mouse anti-VCP were from
Abnova (Tapei, Taiwan) and Thermo Scientific, respectively. Mouse anti-a-tubulin
and rabbit anti-phospho eIF2a were from Sigma-Aldrich (Milan, Italy). Rabbit
anti-LC3 (Novus Biologicals Ltd, Cambridge, UK) was used in the majority of our
experiments, unless otherwise indicated.
The secondary antibodies used are listed. All the Alexa-conjugated secondary
antibodies were from Life Technologies: donkey-anti-goat-Alexa488, donkey-anti-
mouse-Alexa594, donkey-anti-rabbit-Alexa594, donkey-anti-rabbit-Alexa488 and
donkey-anti-mouse-Alexa488. Mouse and rabbit HRP-conjugated secondary
antibodies for western blot were from GE Healthcare Europe GmbH (Milan, Italy).
The reagents used in this study are as follows: ammonium chloride (A9434),
chloroquine (C6628), OP-puro (P8833), sodium arsenite (Carlo Erba Reagents,
Cornaredo, Italy), z-Leu-Leu-Leu-al (MG132; C2211), cycloheximide (C7698) and
tetracycline hydrochloride (T7660) were from Sigma-Aldrich. EerI (sc-358130) was
from Santa Cruz Biotechnology, Inc. Bort. (S1013) was from Selleck Chemicals
(Munich, Germany); ML240 was a kind gift from Prof. RJ Deshaies.
Statistics, analysis of SG size and quantification of colocaliza-
tion. Student’s t-test was used for comparisons between two groups. One-way
ANOVA followed by Bonferroni–Holm post-hoc test was used for comparisons
between three or more groups. *Po0.05; **Po0.01; ***Po0.001.
SG size was measured using ImageJ software (http://rsb.info.nih.gov/ij/).
Average size of 300 SGs is reported.
Colocalization efficiency of RPL19 with TIA-1 in SGs was performed using
ImageJ software (Image J, Colocalization Coloc 2, Manders’ correlation). Region-of-
Interest (ROI) were drawn around single cells. Background and threshold correction
were applied for each ROI.
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